Testosterone Cypionate
- Product NDC
- 0409-6562
- Requested package NDC
- 0409-6562-22
- 11-digit product format
- 004096562
- Labeler code
- 0409
- Product ID
- 0409-6562_e56a4a35-f147-4f61-b47c-37aea1e6e558
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- testosterone cypionate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Hospira, Inc.
- Application
- ANDA085635
- Marketing category
- ANDA
- Marketing start
- 2016-08-01
- Substance
- TESTOSTERONE CYPIONATE
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0409-6562 | 0409-6562-22 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0409-6562 | 0409-6562-22 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 0409-6562 | 0409-6562-22 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A085635-001 | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | ||
| A085635-002 | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | |
| A085635-003 | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A085635-002 | AO |
| A085635-003 | AO |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085635-002 | DEPO-TESTOSTERONE | 100MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085635-003 | DEPO-TESTOSTERONE | 200MG/ML | INJECTABLE / INJECTION | AO | RLD, RS, Approved before 1982 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085635-001 | DEPO-TESTOSTERONE | 50MG/ML | INJECTABLE / INJECTION | Approved before 1982 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A085635-002 | AO | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A085635-003 | AO | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A085635-002 | AO | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A085635-003 | AO | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085635-002 | AO | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085635-003 | AO | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A085635-002 | AO | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A085635-003 | AO | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085635-002 | AO | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085635-003 | AO | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085635-002 | AO | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085635-003 | AO | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085635-002 | AO | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085635-003 | AO | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085635-002 | AO | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085635-003 | AO | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085635-002 | AO | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085635-003 | AO | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085635-002 | AO | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085635-003 | AO | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A085635-002 | AO | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A085635-003 | AO | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085635-002 | AO | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085635-003 | AO | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085635-002 | AO | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085635-003 | AO | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085635-002 | AO | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085635-003 | AO | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A085635-002 | AO | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A085635-003 | AO | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A085635-002 | AO | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A085635-003 | AO | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A085635-002 | AO | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A085635-003 | AO | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A085635-002 | AO | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A085635-003 | AO | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A085635-002 | AO | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A085635-003 | AO | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A085635-002 | AO | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A085635-003 | AO | 1 | bb7c543d1eb4… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Testosterone Cypionate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TESTOSTERONE CYPIONATE | 200 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| M0XW1UBI14 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6909596e-4bf7-4e11-8029-b89740a30aec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2db4fc38-a116-b0ab-3dae-57df54e5f212 | Product name | 2 | 20250121 |
| 386d1b2a-e9b7-0c83-111f-2a77b92895b3 | Product name | 5 | 20240422 |
| 7d55b53c-798b-47ae-992b-3921493a8303 | Product name | 1 | 20230322 |
| 8d753fd6-75b2-4f12-bcbf-339392960afa | Product name | 1 | 20230303 |
| 4fbda828-a5be-46fe-83ec-a88da4359919 | Product name | 1 | 20230104 |
| 93cc9bee-8bdc-273d-ec7f-c2c52535317a | Product name | 7 | 20210902 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 5 | 20210601 |
| f4f0889f-ee8b-471f-9a37-02a035280637 | Product name | 1 | 20200122 |
| 09e1afd3-f431-4380-82c5-438884c25615 | Product name | 1 | 20190111 |
| a6389cd1-36d1-4b5c-9934-1139bee93605 | Product name | 3 | 20171212 |
| 502efed8-01a5-ef6a-61c6-fe8302b6e26b | Product name | 2 | 20171113 |
| 8b700cfd-17dd-41a2-90f5-a80ae8a989a2 | Product name | 1 | 20171113 |
| 9ce0e503-4ae7-2c6a-39ae-85285c29db68 | Product name | 2 | 20171113 |
| 96bdf4b3-71cd-433d-9723-89e50f852992 | Product name | 1 | 20150810 |
| ed2e617f-f28a-1df1-f9fc-c79702f31271 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-6562-01 | Testosterone Cypionate | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 10 | |
| 0409-6562-01 | Testosterone Cypionate | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 10 | |
| 0409-6562-20 | Testosterone Cypionate | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 10 | |
| 0409-6562-20 | Testosterone Cypionate | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-6562-02 | ML - Milliliter | 0409-6562 | f2c2eb43-0dd6-479d-8d59-94a188c2f1c8 | 1 | 2018-02-20 |
| 0409-6562-22 | ML - Milliliter | 0409-6562 | 94373ad6-8d9a-43c4-bb8d-8bc45ccec2b0 | 1 | 2018-02-20 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-6562 | TESTOSTERONE CYPIONATE INJECTION, SOLUTION [HOSPIRA, INC.] | 8 | Current NDC, Legacy NDC, 4 package rows | 20200819_6909596e-4bf7-4e11-8029-b89740a30aec.zip |
| 0409-6562 | TESTOSTERONE CYPIONATE INJECTION, SOLUTION [HOSPIRA, INC.] | 3 | Current NDC, Legacy NDC | 20200819_c5efc1ed-dd50-48fe-81b6-4d691a178630.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Pharmacia & Upjohn Company LLC | cfbb53d4-b868-4a28-8436-f9112eb01c39 | 2025-09-29 | Warnings, Adverse reactions | 085635 ANDA085635 |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Asclemed USA, Inc. | 2f72be32-ede6-44d9-88a0-0653b53a3e47 | 2025-08-27 | Warnings, Adverse reactions | 085635 ANDA085635 |
| Testosterone Cypionate | TESTOSTERONE CYPIONATE | Hospira, Inc. | 6909596e-4bf7-4e11-8029-b89740a30aec | 2025-08-22 | Warnings, Adverse reactions | 085635 ANDA085635 0409-6562 |
| Depo-Testosterone | TESTOSTERONE CYPIONATE | Pharmacia & Upjohn Company LLC | 735b5bf3-4464-412c-a072-1bd02f2e5380 | 2025-07-14 | Warnings, Adverse reactions | 085635 ANDA085635 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 835829 | testosterone cypionate 100 MG/ML Injectable Solution | PSN | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 2047882 | testosterone cypionate 200 MG in 1 ML Injection | PSN | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 835840 | testosterone cypionate 200 MG/ML Injectable Solution | PSN | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 2047882 | 1 ML testosterone cypionate 200 MG/ML Injection | SCD | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 835829 | testosterone cypionate 100 MG/ML Injectable Solution | SCD | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 835840 | testosterone cypionate 200 MG/ML Injectable Solution | SCD | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 835829 | testosterone cypionate 1000 MG per 10 ML Injectable Solution | SY | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
| 2047882 | testosterone cypionate 200 MG per 1 ML Injection | SY | 6909596e-4bf7-4e11-8029-b89740a30aec | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0409-6562-22 | 00409656222 | 1 VIAL in 1 CARTON (0409-6562-22) > 10 mL in 1 VIAL | 1 vial | 2018-01-17 | 0000-00-00 | No | No | Current |